Growth Hormone Research

Ipamorelin is a synthetic pentapeptide acting as a selective agonist at the ghrelin receptor (GHSR-1a). That selectivity is why it appears so often in endocrinology research — it allows growth-hormone-axis signalling to be studied in isolation, without the broader hormonal activity seen with less selective secretagogues.

This vial contains 10mg of ipamorelin as a lyophilized powder, equivalent to approximately 14.05 µmol.

• Vial contents: 10mg lyophilized powder (batch IPA-10-260801-L001 tested at 10.72mg)
• Molar content: approximately 14.05 µmol per vial (based on labeled mass)
• Molecular weight: 711.9 g/mol
• Classification: Selective growth-hormone secretagogue, ghrelin receptor agonist
• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2 (C-terminal amide)
• Purity: 99.296% by RP-HPLC (batch IPA-10-260801-L001) — see COA

For laboratory research use only. Not for human or veterinary use.

CJC-1295 without DAC, also called Modified GRF (1-29), is a 29-residue analog of growth-hormone-releasing hormone carrying four amino acid substitutions that improve its stability relative to native GRF. It lacks the Drug Affinity Complex moiety found in the long-acting version, which makes it a distinct molecule rather than a variant.

This vial contains 10mg of CJC-1295 without DAC as a lyophilized powder, equivalent to approximately 2.97 µmol.

• Vial contents: 10mg lyophilized powder (batch CND-10-260801-L001 tested at 10.41mg)
• Molar content: approximately 2.97 µmol per vial (based on labeled mass)
• Molecular weight: 3367.9 g/mol
• Classification: GHRH receptor agonist analog, DAC-free form
• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
• Purity: 99.413% by RP-HPLC (batch CND-10-260801-L001) — see COA

For laboratory research use only. Not for human or veterinary use.